Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00521885 · ClinicalTrials.gov registry record · NA
Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill Patients
A NA study, sponsored by Lehigh Valley Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT00521885: Clinical Trial NA study, sponsored by Lehigh Valley Hospital.
NCT00521885 is a NA study that was terminated before completion, run by Lehigh Valley Hospital. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00521885, a NA study, was terminated before completion, sponsored by Lehigh Valley Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
A total of 50 patients \>40 yrs of age with an expected hospital stay in the Medical Intensive Care or Regional Heart Unit at LVH Muhlenberg of 6 days or longer will be enrolled. The patient and study team will be blinded to which drug they are receiving (either Arixtra or Lovenox). Subjects will be examined for any bleeding complications. Subjects will receive drug for a total of 6-14 days while in the hospital. A follow up phone call will be performed by the study team approximately 30 days after discharge from the hospital.
Primary Outcome
Bleeding Rate- Major bleeding defined as one or a combination of the following: Fatal; Bleeding at critical organ sites (intracranial, retroperitoneal, intraocular, pericardial, spinal or adrenal). Minor Bleeding defined as clinically overt bleeding that is not major bleeding.
Interventions
- DRUG Arixtra (Fondaparinox) 2.5 mg SC Daily
- DRUG Lovenox 40mg SC Daily
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2007-09 |
| Est. Completion | 2009-09 |
| Phase | NA |
Why NCT00521885 stopped before completion
NCT00521885 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Arixtra (Fondaparinox) 2.5 mg SC Daily is the first listed.
NCT00521885 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00521885 about?
NCT00521885 is a clinical study titled "Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill Patients". A total of 50 patients \>40 yrs of age with an expected hospital stay in the Medical Intensive Care or Regional Heart Unit at LVH Muhlenberg of 6 days or longer will be enrolled. The patient and study team will be blinded to which drug they are receiving (either Arixtra or Lovenox). Subjects will be...
What is the current status of trial NCT00521885?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2007-09. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00521885?
The interventions under investigation include: Arixtra (Fondaparinox) 2.5 mg SC Daily (DRUG), Lovenox 40mg SC Daily (DRUG).
Who is sponsoring clinical trial NCT00521885?
This trial is sponsored by Lehigh Valley Hospital, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00521885's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia